• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Quick Take: Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease

byKyle HoffmanandAliya Ramjaun
March 17, 2019
in Chronic Disease, Nephrology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

RELATED REPORTS

Sodium bicarbonate does not prevent declining kidney function in kidney transplant recipients

Cystatin C-based equation without race or sex improves accuracy of GFR estimation

Dapagliflozin reduces the risk of hospitalization in patients with chronic kidney disease

Chronic metabolic acidosis is often seen in patients with chronic kidney disease (CKD), and results from an inability to excrete metabolically produced acid. This, in turn, is associated with bone resorption, muscle catabolism, and progression of kidney disease. Veverimer is a non-absorbable medication that removes hydrochloric acid from the gut lumen in order to combat acidosis. In this multicenter, randomized controlled trial, 217 patients age 18 to 85 years with non-dialysis dependent CKD (estimated glomerular filtration rate between 20 and 40 mL/minute per 1.73 m2) with metabolic acidosis (serum bicarbonate between 12 and 20 mmol/L) were randomly assigned to receive either veverimer or placebo for 12 weeks while adhering to their regular diet to assess the efficacy and safety of veverimer as a treatment for metabolic acidosis in this patient population. Patients were followed up for the composite primary end point, which was the difference in the proportion of patients achieving either a 4 mmol/L increase in serum bicarbonate concentration from baseline or a serum bicarbonate level in the normal range of 22-29 mmol/L. Researchers found that there was a significant increase in the proportion of patients achieving the composite primary endpoint in the veverimer group, as compared to placebo (59% vs. 22%, difference 37%, 95% CI 23% to 49%, p<0.0001). The most common treatment-related adverse events observed in the interventional group were gastrointestinal, including diarrhea, flatulence, nausea, and constipation; these events were typically mild to moderate in severity. This study therefore shows that veverimer is a safe and effective therapy for metabolic acidosis in patients with CKD. Further studies are needed in investigating the long-term effect and safety of this medication.

Click to read the study in Lancet

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: chronic kidney disease (CKD)metablic acidosisveverimer
Previous Post

Quick Take: Association of Atopic Dermatitis With Sleep Quality in Children

Next Post

#VisualAbstract: Bag-Mask Ventilation during Tracheal Intubation of Critically Ill Adults

RelatedReports

Tenofovir disoprovil fumarate HIV prophylaxis linked with minimal kidney impact
Chronic Disease

Sodium bicarbonate does not prevent declining kidney function in kidney transplant recipients

March 15, 2023
Intravenous contrast may not increase risk of acute kidney injury
Chronic Disease

Cystatin C-based equation without race or sex improves accuracy of GFR estimation

February 3, 2023
Solitary kidney not associated with contrast-induced nephropathy
Chronic Disease

Dapagliflozin reduces the risk of hospitalization in patients with chronic kidney disease

December 26, 2022
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Nephrology Classics

Gadolinium-containing contrast associated with nephrogenic fibrosing dermopathy and systemic fibrosis [Classics Series]

September 5, 2022
Next Post
#VisualAbstract: Bag-Mask Ventilation during Tracheal Intubation of Critically Ill Adults

#VisualAbstract: Bag-Mask Ventilation during Tracheal Intubation of Critically Ill Adults

Direct oral anticoagulants for atrial fibrillation in patients with mitral stenosis

Direct oral anticoagulants for atrial fibrillation in patients with mitral stenosis

Quick Take: Impact of scribes on emergency medicine doctors’ productivity and patient throughput: multicentre randomised trial

Psychiatric emergency visits increasing among youth, especially racial minorities

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Childhood maltreatment may cause mental health problems
  • #VisualAbstract: Hydrochlorothiazide does not impact risk of kidney-stone recurrence
  • Metformin use may decrease risk of osteoarthritis development
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options